Sign in
4

Changes in Ownership

SELLAS Life Sciences Group, Inc. Filed Acc 0001104659-25-003494

SVP, Chief Development Officer acquired 194,300 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
CICIC DRAGAN SVP, Chief Development Officer 2025-01-10 Grant or award +113,000 228,328 D
CICIC DRAGAN SVP, Chief Development Officer 2025-01-10 Grant or award +81,300 309,628 D
Derivatives
CICIC DRAGAN SVP, Chief Development Officer 2025-01-10 Grant or award · Stock Option (Right to Buy) +169,500 169,500 D
Loading xslF345X05/tm253166-1_4seq1.xml…